title: [Epidermal growth factor receptor inhibitors side effects].
abstract: Epidermal growth factor receptor (EGFR) inhibitors are a new group of drugs used in the treatment of several malignancies. Three molecules are approved at the moment: gefitinib and erlotinib for the treatment of non-small-cell lung cancer, and cetuximab for colorectal cancer. These drugs originate cutaneous side effects with a high frequency: acneiform rashes, paronychia and generalized xerodermia. In this paper we review these common side effects and how to manage them.
authors.affiliation: Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, España. guhl@aedv.es
authors.forename: Guillermo
authors.initials: G
authors.lastname: Guhl
authors.forename: Ana
authors.initials: A
authors.lastname: González-de Arriba
authors.forename: Esteban
authors.initials: E
authors.lastname: Daudén
mesh_terms: D017486:Acneiform Eruptions / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans
chemical_list: D066246:ErbB Receptors